Milan, Italy / Ulm, Germany – November 2018
Exom Group, the Expert Digital CRO, proudly announces that it has been awarded one of Europe’s Top 10 CROs that are spearheading innovation and impacting the industry. “This award shows that Exom’s innovative strategy of implementing novel digital solutions into managing clinical trials, is exactly what the industry is looking for.”, says Dr. Luigi Visani, President & CEO of Exom Group.
Exom’s Genius SUITE of fully integrated solutions offers its clients tools ranging from CTMS, eTMF and eCRF up to more sophisticated software such as electronic informed consents which significantly benefits patient recruitment and retention, by giving the study participants a better understanding of the study procedures at hand. Besides this Exom is working on solutions containing telehealth, which will enable certain study visits to be conducted at home, by e.g. utilizing video chat and health devices connected to the patients’ smartphone (e.g., glucose meters, spirometers, etc.).
“Exom is dedicated to bringing forward the digitalization of the clinical research industry.”, says Dr. Visani. “And this award shows that we are going the right direction. We will continue to develop and offer the most innovative services and solutions to our clients.”, he concluded.
Exom is a Milan, Italy based CRO, which is committed to the modernization of Clinical Trials through Digital Transformation and Patient Engagement. By combining its expertise across medical, regulatory and operational functions with its proprietary, multi-modular and cloud based platform Genius SUITE™, Exom improves efficiencies and escalate process speeds while ensuring data quality and costs reduction, from Early Phase to Late & Outcome Studies.
Exom Group Srl
Viale F. Restelli 3/1
20124 Milan (Italy)
Ph. +39 02 36725581
Fax +39 02 36725580